...
首页> 外文期刊>World Journal of Gastroenterology >Additional laparoscopic gastrectomy after noncurative endoscopic submucosal dissection for early gastric cancer: A single-center experience
【24h】

Additional laparoscopic gastrectomy after noncurative endoscopic submucosal dissection for early gastric cancer: A single-center experience

机译:额外的腹腔镜胃切除术后,用于早期胃癌的非耐久性内窥镜粘膜切除术:单中心经验

获取原文
           

摘要

The necessity of additional gastrectomy for early gastric cancer (EGC) patients who do not meet curative criteria after endoscopic submucosal dissection (ESD) is controversial. To examine the clinicopathologic characteristics of patients who underwent additional laparoscopic gastrectomy after ESD and to determine the appropriate strategy for treating those after noncurative ESD. We retrospectively studied 45 patients with EGC who underwent additional laparoscopic gastrectomy after noncurative ESD from January 2013 to January 2019 at the Cancer Hospital of the Chinese Academy of Medical Sciences. We analyzed the patients' clinicopathological data and identified the predictors of residual cancer (RC) and lymph node metastasis (LNM). Surgical specimens showed RC in ten (22.2%) patients and LNM in five (11.1%). Multivariate analysis revealed that positive horizontal margin [odds ratio (OR) = 13.393, 95% confidence interval (CI): 1.435-125, P = 0.023] and neural invasion (OR = 14.714, 95%CI: 1.087-199, P = 0.043) were independent risk factors for RC. Undifferentiated type was an independent risk factor for LNM (OR = 12.000, 95%CI: 1.197-120, P = 0.035). Tumors in all patients with LNM showed submucosal invasion more than 500 μm. Postoperative complications after additional laparoscopic gastrectomy occurred in five (11.1%) patients, and no deaths occurred among patients with complications. Gastrectomy is necessary not only for patients who have a positive margin after ESD, but also for cases with neural invasion, undifferentiated type, and submucosal invasion more than 500 μm. Laparoscopic gastrectomy is a safe, minimally invasive, and feasible procedure for additional surgery after noncurative ESD. However, further studies are needed to apply these results to clinical practice.
机译:用于早期胃癌(EGC)患者的额外胃切除术的必要性,该患者在内窥镜粘膜下解剖(ESD)后不符合疗法标准(ESD)是有争议的。检查ESD后接受额外腹腔镜胃切除术的患者的临床病理特征,并确定非耐久性ESD后的适当策略。我们回顾性研究了45例EGC患者,在2013年1月至2019年1月在中国医学科学院癌症医院完成了腹腔镜胃切除术后额外的腹腔镜胃切除术。我们分析了患者的临床病理数据,并确定了残留癌症(RC)和淋巴结转移(LNM)的预测因子。手术标本在10名(22.2%)患者中的rc(22.2%)患者,其中5例(11.1%)。多变量分析表明,正水平边缘[差距(或)= 13.393,95%置信区间(CI):1.435-125,P = 0.023]和神经侵袭(或= 14.714,95%CI:1.087-199,P = 0.043)是RC的独立风险因素。未分化的类型是LNM的独立风险因子(或= 12.000,95%CI:1.197-120,P = 0.035)。所有LNM患者的肿瘤显示粘膜侵袭超过500μm。在额外的腹腔镜胃切除术后发生术后并发症,在五(11.1%)患者中发生,并且在并发症的患者中没有发生死亡。胃切除术不仅是在ESD后阳性边缘的患者的必要条件,而且对于具有神经侵袭,未分化的类型和粘膜侵袭超过500μm的病例。腹腔镜胃切除术是一种安全,微创,可行的侵袭性和可行的过程,用于在非耐久性ESD后额外的手术。然而,需要进一步的研究来将这些结果应用于临床实践。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号